Inclusion Criteria:
To qualify for participation in this study, individuals must meet the following minimum criteria (additional criteria may also apply):

• Diagnosed with type 1 diabetes (per ADA criteria) more than 3 but less than 48 months prior to enrollment
• Aged 18-45 years old
• positive for at least one islet cell autoantibody (GAD65-antibody, CA512-antibody and/or ICA)

Exclusion Criteria:
Individuals meeting any of the criteria below will not be eligible to participate in the study. Additional exclusion criteria may apply.

• chronic use of glucocorticoids or other immunosuppressive agents within 4 weeks before enrollment
• History of recurrent infections, other autoimmune diseases, cardiac disease, cataracts or other chronic medical conditions that investigators believe could compromise participant safety
• females who are pregnant, lactating intend to get pregnant, or are unwilling to undergo pregnancy testing during the study
• males who intend to father a pregnancy during the first 6 months of the study
• participation in another clinical study within the last 30 days

Proleukin & Rapamune
Trial Information:

Overview
A description of the rationale, design treatments used for the study

>> Eligibility <<
Inclusion and exclusion criteria for the study.

Locations & Contacts
Where the study is being conducted, with contact information.